talipexole has been researched along with Disease Exacerbation in 1 studies
talipexole: dopamine receptor agonist; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Talipexole hydrochloride has been on market in Japan recently, but MAO-B inhibitors and COMT inhibitors are in final stages to wait evaluations by the governmental committee." | 2.40 | [Clinical characteristics and trends in research of Parkinson's disease and parkinsonism in Japan]. ( Yanagisawa, N, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yanagisawa, N | 1 |
1 review available for talipexole and Disease Exacerbation
| Article | Year |
|---|---|
[Clinical characteristics and trends in research of Parkinson's disease and parkinsonism in Japan].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azepines; Child; Child, Preschool; Disease Progression; | 1997 |